Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates.

@article{Heile2000EvaluationOH,
  title={Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates.},
  author={J M Heile and Y L Fong and Domenico Rosa and Kim Berger and Giulietta Saletti and Susanna Campagnoli and Giuliano Bensi and Sabrina Capo and Stephen A. Coates and Kevin R Crawford and Christine Yang Dong and Mark Wininger and Gary Baker and L C Cousens and David M Chien and Philip Ng and P Archangel and Guido Grandi and Michael Houghton and Sergio Abrignani},
  journal={Journal of virology},
  year={2000},
  volume={74 15},
  pages={
          6885-92
        }
}
Hepatitis C virus (HCV) is the leading causative agent of blood-borne chronic hepatitis and is the target of intensive vaccine research. The virus genome encodes a number of structural and nonstructural antigens which could be used in a subunit vaccine. The HCV envelope glycoprotein E2 has recently been shown to bind CD81 on human cells and therefore is a prime candidate for inclusion in any such vaccine. The experiments presented here assessed the optimal form of HCV E2 antigen from the… CONTINUE READING
Highly Cited
This paper has 28 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 51 references

Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells

R. R. Spaete, A. D’Anna, +11 authors M. Houghton
Virology • 1992
View 4 Excerpts
Highly Influenced